{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:45:55Z","timestamp":1765302355734,"version":"3.46.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coccidioidomycosis is a fungal infection endemic to the southwestern United States. Central nervous system (CNS) coccidioidomycosis is a severe manifestation that requires lifelong antifungal therapy. While fluconazole is currently recommended as the initial therapy in pediatric patients, a rise in reports of fluconazole failure has led to use of alternative treatment approaches. In this paper, we evaluated our institutional preference to use intravenous (IV) liposomal amphotericin B (L-AmB) as part of the initial therapy for pediatric CNS coccidioidomycosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective case series of pediatric patients diagnosed with CNS coccidioidomycosis between 2010 and 2024. Clinical presentation, diagnostics, treatment strategies, and outcomes were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 10 patients, 6 had mild initial symptoms of fevers and\/or headaches, while 4 had more severe initial presentations, including focal deficits, seizures, or altered mental status. All severe cases received immediate IV L-AmB and fluconazole (+IV L-AmB); 75% were discharged with improvement. The 2 mild cases that received early +IV L-AmB had uncomplicated courses, while 2 of the 4 mild cases initially treated with fluconazole alone progressed to severe disease. Over an average follow-up of 4.5\u00a0years, 5 patients were fully functional without neurologic deficits, 2 had mild residual deficits, and 3 died. Relapse occurred in all but 1 patient. Patients receiving early +IV L-AmB trended toward shorter hospitalizations, lower disease progression rates, and delayed disease relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our institutional experience with IV L-AmB in combination with fluconazole for the initial management of pediatric CNS coccidioidomycosis suggests that +IV L-AmB may help reduce disease progression and improve symptom resolution with mild and transient side effects, although the findings of this case series should be interpreted cautiously due to the small cohort size, limited generalizability, and potential confounding factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpids\/piaf103","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:29:45Z","timestamp":1762777785000},"source":"Crossref","is-referenced-by-count":0,"title":["Intravenous Liposomal Amphotericin as an Adjunct to Fluconazole in Pediatric Patients With Central Nervous System Coccidioidomycosis: A Single-Center Case Series"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-5893","authenticated-orcid":false,"given":"Kajal","family":"Maran","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Division of Child Neurology, Stanford University , Palo Alto, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruzan","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, Stanford University , Palo Alto, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4735-2700","authenticated-orcid":false,"given":"Aslam","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, Stanford University , Palo Alto, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3705-258X","authenticated-orcid":false,"given":"Sharon F","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, Stanford University , Palo Alto, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2025120912413471500_ref1","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/B978-0-323-82763-8.00218-1","volume-title":"Feigin and Cherry's Textbook of Pediatric Infectious","author":"Shehab","year":"2025","edition":"Diseases 9th"},{"key":"2025120912413471500_ref2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1128\/JCM.02230-06","article-title":"Epidemiologic, clinical, and diagnostic aspects of Coccidioidomycosis","volume":"45","author":"Saubolle","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2025120912413471500_ref3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1086\/497596","article-title":"Coccidioidal meningitis","volume":"42","author":"Goldstein","year":"2006","journal-title":"Clin Infect Dis"},{"volume-title":"Substantial Rise in Coccidioidomycosis in California: Recommendations for California Healthcare Providers","year":"2024","key":"2025120912413471500_ref4"},{"key":"2025120912413471500_ref5","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of Coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025120912413471500_ref6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/jof8111157","article-title":"Fluconazole failure in the treatment of Coccidioidal meningitis","volume":"8","author":"Gupta","year":"2022","journal-title":"J Fungi"},{"key":"2025120912413471500_ref7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/INF.0000000000003813","article-title":"Central nervous system Coccidioidomycosis in children: A retrospective case series","volume":"42","author":"Naeem","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"2025120912413471500_ref8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/00006454-200012000-00018","article-title":"Fluconazole treatment of coccidioidal meningitis in children: Two case reports and a review of the literature","volume":"19","author":"Saitoh","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"2025120912413471500_ref9","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1097\/INF.0000000000004888","article-title":"Pearls and pitfalls of intrathecal amphotericin B therapy for refractory Coccidioidal meningitis in children","volume":"44","author":"Malhotra","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"2025120912413471500_ref10","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1097\/INF.0000000000003017","article-title":"Isavuconazole as salvage therapy for refractory Pediatric Coccidioidal meningitis","volume":"40","author":"Naeem","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2025120912413471500_ref11","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/cid\/cit113","article-title":"Treatment of Pediatric refractory Coccidioidomycosis with combination Voriconazole and Caspofungin: A retrospective case series","volume":"56","author":"Levy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2025120912413471500_ref12","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1056\/NEJMoa2000024","article-title":"Disseminated Coccidioidomycosis treated with interferon-\u03b3 and Dupilumab","volume":"382","author":"Tsai","year":"2020","journal-title":"N Engl J Med"},{"key":"2025120912413471500_ref13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11046-017-0240-7","article-title":"Liposomal amphotericin B as monotherapy in relapsed coccidioidal meningitis","volume":"183","author":"Stewart","year":"2018","journal-title":"Mycopathologia"},{"key":"2025120912413471500_ref14","first-page":"940","article-title":"Successful use of combination antifungal therapy in the treatment of Coccidioides meningitis","volume":"98","author":"Antony","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"2025120912413471500_ref15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the Management of Patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2025120912413471500_ref16","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/AAC.42.11.3018","article-title":"Organism-dependent fungicidal activities of azoles","volume":"42","author":"Manavathu","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2025120912413471500_ref17","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1128\/AAC.00345-07","article-title":"Differential fungicidal activities of amphotericin B and Voriconazole against aspergillus species determined by microbroth methodology","volume":"51","author":"Meletiadis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2025120912413471500_ref18","first-page":"339","article-title":"Coccidioidal meningitis \u2013 The use of amphotericin B in treatment","volume":"94","author":"Einstein","year":"1961","journal-title":"Calif Med"},{"key":"2025120912413471500_ref19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0002-9343(59)90046-4","article-title":"The use of amphotericin B in the treatment of coccidioidal disease","volume":"27","author":"Winn","year":"1959","journal-title":"Am J Med"},{"key":"2025120912413471500_ref20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"2025120912413471500_ref21","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1128\/AAC.46.8.2420-2426.2002","article-title":"Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits","volume":"46","author":"Clemons","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2025120912413471500_ref22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/jac\/dkm264","article-title":"Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis","volume":"60","author":"Capilla","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2025120912413471500_ref23","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1128\/AAC.01538-08","article-title":"Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits","volume":"53","author":"Clemons","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2025120912413471500_ref24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/jof5030054","article-title":"Central nervous system infections due to Coccidioidomycosis","volume":"5","author":"Jackson","year":"2019","journal-title":"J Fungi"},{"key":"2025120912413471500_ref25","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.15585\/mmwr.mm6948a4","article-title":"Regional analysis of Coccidioidomycosis incidence \u2014 California, 2000\u20132018","volume":"69","author":"Sondermeyer Cooksey","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025120912413471500_ref26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7326\/0003-4819-137-2-200207160-00008","article-title":"Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS","volume":"137","author":"Johnson","year":"2002","journal-title":"Ann Intern Med"},{"key":"2025120912413471500_ref27","doi-asserted-by":"publisher","first-page":"CD010481","DOI":"10.1002\/14651858.CD010481.pub2","article-title":"Amphotericin B deoxycholate versus liposomal amphotericin B: Effects on kidney function","volume":"2015","author":"Botero Aguirre","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"volume-title":"Application and Interpretation of Serologic Tests","year":"2014","author":"Thompson","key":"2025120912413471500_ref28"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piaf103\/65269183\/piaf103.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/12\/piaf103\/65269183\/piaf103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/12\/piaf103\/65269183\/piaf103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:41:39Z","timestamp":1765302099000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/doi\/10.1093\/jpids\/piaf103\/8320487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piaf103","relation":{},"ISSN":["2048-7207"],"issn-type":[{"type":"electronic","value":"2048-7207"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,11]]},"article-number":"piaf103"}}